High-throughput screening and dynamic studies of selected compounds against sars-cov-2 R Bhowmik, R Nath, S Sharma, R Roy, R Biswas Int J Appl Pharm 14, 251-260, 2022 | 9 | 2022 |
Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based … R Bhowmik, R Kant, A Manaithiya, D Saluja, B Vyas, R Nath, KA Qureshi, ... Frontiers in Pharmacology 14, 1265573, 2023 | 8 | 2023 |
Identification, analysis of deleterious SNPs of the human GSR gene and their effects on the structure and functions of associated proteins and other diseases B Vyas, R Bhowmik, M Akhter, FJ Ahmad Scientific Reports 12 (1), 5474, 2022 | 7 | 2022 |
Identification of potential inhibitor against Ebola virus VP35: insight into virtual screening, pharmacoinformatics profiling, and molecular dynamic studies R Bhowmik, A Manaithiya, B Vyas, R Nath, S Rehman, S Roy, R Roy Structural Chemistry 33 (3), 815-831, 2022 | 6 | 2022 |
Mycobacterial β-carbonic anhydrases: molecular biology, role in the pathogenesis of tuberculosis and inhibition studies J Parkkinen, ME Tovanen, F Carta, C Supuran, S Parkkila, A Aspatwar Bacterial carbonic anhydrases 55, 2024 | 4 | 2024 |
Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors S Kumar, R Bhowmik, JM Oh, MA Abdelgawad, MM Ghoneim, ... Scientific Reports 14 (1), 4868, 2024 | 4 | 2024 |
Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach B Vyas, S Kumar, R Bhowmik, M Akhter Scientific Reports 13 (1), 13729, 2023 | 4 | 2023 |
Computer aided drug design of florfenicol to target chloramphenicol acetyltransferase of vibriosis causing pathogens R Bhowmik, S Roy, S Sengupta, L Ravi J. Appl. Biol. Biotech 10, 76-84, 2022 | 3 | 2022 |
Elucidating molecular mechanism and chemical space of chalcones through biological networks and machine learning approaches A Manaithiya, R Bhowmik, S Acharjee, S Sharma, S Kumar, M Imran, ... Computational and structural biotechnology journal 23, 2811-2836, 2024 | 2 | 2024 |
Probing the origins of programmed death ligand-1 inhibition by implementing machine learning-assisted sequential virtual screening techniques S Kuttappan, R Bhowmik, C Gopi Mohan Molecular Diversity 28 (4), 2449-2466, 2024 | 1 | 2024 |
Pharmacoinformatics Profiling and Dynamic Studies of Selected Compounds Acting as Potential Inhibitors against DPP4 Enzyme. S Roy, R Bhowmik, S Sengupta, S Sharma, B Vyas, IA Khan Oriental Journal of Chemistry 37 (5), 2021 | 1 | 2021 |
Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism S Giovannuzzi, SS Shyamal, R Bhowmik, R Ray, A Manaithiya, F Carta, ... Computers in Biology and Medicine 181, 109029, 2024 | | 2024 |
A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors A Manaithiya, R Bhowmik, K Bhattacharya, R Ray, SS Shyamal, F Carta, ... Frontiers in Pharmacology 15, 1457012, 2024 | | 2024 |
Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based … R Bhowmik, R Kant, A Manaithiya, D Saluja, B Vyas, R Nath, KA Qureshi, ... FRONTIERS IN PHARMACOLOGY 14, 2024 | | 2024 |
Corrigendum: Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular … R Bhowmik, R Kant, A Manaithiya, D Saluja, B Vyas, R Nath, KA Qureshi, ... Frontiers in Pharmacology 14, 1340724, 2024 | | 2024 |